N.alpha.-(O,O'-Diphenoxyphosphoryl)-L-alanyl-L-proline, N.alpha.-[O,O'-bis(4-nitrophenoxy)phosphoryl]-L-alanyl-L-proline and N.alpha.-[P-(2-phenylethyl)-O-phenoxyphosphoryl]-L-alanyl-L-proline: releasers of potent inhibitors of angiotensin converting enzyme at physiological pH and temperature
- 1 October 1985
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 28 (10) , 1422-1427
- https://doi.org/10.1021/jm00148a008
Abstract
The rate of loss of phenol or 4-nitrophenol from Na-(diphenoxyphosphoryl)-L-alanyl-L-proline (2), N.alpha.-[bis(4-nitrophenoxy)phosphoryl]-L-alanyl-L-proline (5) and N.alpha.[(2-phenylethyl)phenoxyphosphoryl]-L-alanyl-L-proline (12) was determined spectrophotometrically at pH 7.5 and 37.degree. C in both Tris and phosphate buffers. These moderately potent inhibitors of angiotensin converting enzyme (Ki > 0.8 .mu.M) all hydrolyze, losing 1 mol of phenol to yield highly potent inhibitors (Ki = 0.5-18 nM). The half-times for loss of 1 mol of phenol in Tris buffer are 22 days (2), 3, 4 h (5), and 21 days (12). The half-times in phosphate buffer were not significantly different. The mono(2-nitrophenoxy)ester 6 (Ki = 18 nM) loses its 1 mol of nitrophenol with a half-time of 35 h to yield Na-phosphoryl-L-alanyl-L-proline 16 (Ki = 1.4 nM), which hydrolyzes at the P-N bond with a half-time of 2.2 h. Hydrolysis of the P-N bond in 2 and 12 was not observed during the time course of the kinetic experiments. The two phosphoramidate diesters 2 and 5 and the phosphonamidate monoester 12 thus release powerful inhibitors of angiotensin converting enzyme with a known time course at physiological pH and temperature in vitro. A time-dependent increase in inhibitory potency against converting enzyme that paralleled the kinetics of phenyl ester hydrolysis was confirmed in vitro.This publication has 10 references indexed in Scilit:
- Inhibition of the elastase of Pseudomonas aeruginosa by N.alpha.-phosphoryl dipeptides and kinetics of spontaneous hydrolysis of the inhibitorsBiochemistry, 1984
- Inhibition of angiotensin converting enzyme by phosphonic amides and phosphonic acidsBiochemistry, 1983
- Inhibition of angiotensin-converting enzyme by phosphoramidates and polyphosphatesBiochemistry, 1982
- Phosphorus-containing inhibitors of angiotensin-converting enzyme.Proceedings of the National Academy of Sciences, 1982
- ANTIHYPERTENSIVE ACTIVITY OF N-[(S)-1-(ETHOXYCARBONYL)-3-PHENYLPROPYL]-L-ALA-L-PRO (MK-421), AN ORALLY ACTIVE CONVERTING ENZYME-INHIBITOR1981
- Inhibition of angiotensin converting enzyme with Nα-phosphoryl-L-alanyl-L-proline and Nα-phosphoryl-L-valyl-L-tryptophanBiochemical and Biophysical Research Communications, 1980
- Design of potent reversible inhibitors for thermolysin. Peptides containing zinc coordinating ligands and their use in affinity chromatographyBiochemistry, 1979
- A crystallographic study of the complex of phosphoramidon with thermolysin. A model for the presumed catalytic transition state and for the binding of extended substratesJournal of Molecular Biology, 1977
- Synthèse de l'Ala1‐Ala6‐Arg8‐vasopressine et de l'Ala1‐Ala6‐Lys8‐vasopressine, ainsi que de la (déamino‐Ala)1‐Ala6‐Arg8‐vasopressine et de la (désamino‐Ala)1‐Ala6‐Lys8‐vasopressineHelvetica Chimica Acta, 1965
- THE CHROMATOGRAPHIC IDENTIFICATION OF SOME BIOLOGICALLY IMPORTANT PHOSPHATE ESTERSJournal of Biological Chemistry, 1951